Skip to main content
Fig. 1 | BMC Neurology

Fig. 1

From: Selected serum cytokines and nitric oxide as potential multi-marker biosignature panels for Parkinson disease of varying durations: a case-control study

Fig. 1

Concentrations of serum immune mediators in Parkinson patients with varying disease durations compared with controls (a) Mean serum IFNγ concentration in pg/ml (< 1-year PD = 41.76[±3.92], 1–3 years PD = 35.82 [±6.17], > 3 years PD = 51.65 [±8.43]) (b) Mean serum IL-10 concentration in pg/ml (< 1-year PD = 27.97[±5.76], 1–3 years PD = 21.69[±4.29], > 3 years PD = 23.86[±4.21]) (c) Mean serum TNFα concentration in pg/ml (< 1-year PD = 12.43[±6.74], 1–3 years PD = 2.5[±4.04], > 3 years PD = 0.98[±2.53]) (d) Mean serum NOx concentration in mmol/dm3 (< 1-year PD = 10.64[±3.59], 1–3 years PD = 18.47[±2.16], > 3 years PD = 15.26[±5.27]). The results are expressed as mean ± SD. ****P < 0.0001 and ***P < 0.001 were considered significant compared to healthy controls (Mann-Whitney U Test)

Back to article page